Accrete Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 4.50 Cr
as on 24-10-2024
- Company Age 20 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.54 Cr
as on 24-10-2024
- Satisfied Charges ₹ 5.95 Cr
as on 24-10-2024
- Revenue 2.52%
(FY 2023)
- Profit 59.15%
(FY 2023)
- Ebitda 46.71%
(FY 2023)
- Net Worth 28.73%
(FY 2023)
- Total Assets 18.50%
(FY 2023)
About Accrete Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.50 Cr.
The company currently has active open charges totaling ₹10.54 Cr. The company has closed loans amounting to ₹5.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
Aileni Reddy, Srinivas Aita, Sukarna Dodle, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239TG2004PTC043737
- Company No.
043737
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jul 2004
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Accrete Pharmaceuticals Private Limited offer?
Accrete Pharmaceuticals Private Limited offers a wide range of products and services, including Graphic Design & Animation Services, Graphic Design Services, Flavours & Aromatics, Food Acidulant, API Intermediate, Imatinib Intermediates, Pharma Ingredients & Raw Materials, Fitness Supplements, Carnitine Tablets, Anti Bacterial & Fungal Extracts.
Who are the key members and board of directors at Accrete Pharmaceuticals?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aileni Reddy  | Director | 17-May-2010 | Current |
| Aileni Dhruva | Director | 14-May-2014 | Current |
| Srinivas Aita | Director | 10-May-2010 | Current |
| Sukarna Dodle | Director | 23-Jul-2004 | Current |
| Maheshwar Parsi | Director | 10-May-2010 | Current |
Financial Performance and Corporate Structure Insights of Accrete Pharmaceuticals.
Accrete Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.52% increase. The company also saw a substantial improvement in profitability, with a 59.15% increase in profit. The company's net worth Soared by an impressive increase of 28.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Accrete Pharmaceuticals?
In 2023, Accrete Pharmaceuticals had a promoter holding of 39.10% and a public holding of 60.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Salvo Industries Private LimitedActive 39 years 10 monthsAileni Reddy and Aileni Dhruva are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 24 May 2024 | ₹1.84 Cr | Open |
Sidbi Creation Date: 12 Mar 2020 | ₹1.70 Cr | Open |
State Bank Of India Creation Date: 07 Jul 2006 | ₹7.00 Cr | Open |
How Many Employees Work at Accrete Pharmaceuticals?
Accrete Pharmaceuticals has a workforce of 52 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Accrete Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accrete Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
